LEADER 01019nam0-22002891i-450- 001 990006565760403321 005 20001010 035 $a000656576 035 $aFED01000656576 035 $a(Aleph)000656576FED01 035 $a000656576 100 $a20001010d--------km-y0itay50------ba 101 0 $aita 105 $ay-------001yy 200 1 $aCodice della strada e principali leggi complementari$etesto unico delle norme sulla circolazione stradale$eindicesistematico e analitico-alfabetico, tabella delle violazioni e relative sansioni articolo perarticolo$fa cura di Polito L. Jascone Ed. agg. al giugno 1987 210 $aRimini$cMaggionli$d1987 215 $aXXXIV, 789., 16 cm 225 1 $a<>codici Maggioli$v77 710 02$aItalia$0423419 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990006565760403321 952 $aXXX COD. 429 (17)$b2843$fFSPBC 959 $aFSPBC 996 $aCodice della strada e principali leggi complementari$9624350 997 $aUNINA DB $aGEN01 LEADER 05335nam 22007335 450 001 9910253894303321 005 20200702195732.0 010 $a3-319-40609-4 024 7 $a10.1007/978-3-319-40609-1 035 $a(CKB)3710000000749199 035 $a(DE-He213)978-3-319-40609-1 035 $a(MiAaPQ)EBC4591925 035 $a(PPN)194516237 035 $a(EXLCZ)993710000000749199 100 $a20160712d2016 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aSubalternity vs. Hegemony, Cuba's Outstanding Achievements in Science and Biotechnology, 1959-2014 /$fby Angelo Baracca, Rosella Franconi 205 $a1st ed. 2016. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2016. 215 $a1 online resource (XII, 103 p.) 225 1 $aSpringerBriefs in History of Science and Technology,$x2211-4564 311 $a3-319-40608-6 320 $aIncludes bibliographical references at the end of each chapters. 327 $aChapter 1. Introduction. Cuba?s exceptional scientific development -- Chapter 2. Meeting subalternity, a constant challenge in Cuban history -- Chapter 3. Addressing the challenge of scientific development: the first steep steps of a long path -- Chapter 4. Reaching a critical mass and laying the foundations of an advanced scientific system -- Chapter 5. The decisive leap in the 1980s: the attainment of Cuba?s scientific autonomy -- Chapter 6. Decisive results ? and new challenges -- Chapter 7. Comparative considerations and Conclusions. 330 $aThe present book introduces an original (new) perspective on Cuba. This book revisits Cuba's choice, after the 1959 revolution, to develop an advanced healthcare and scientific system. It also introduces new aspects of the problem development/underdevelopment. From the start, every effort of the Cuban leadership and scientific community was driven by the primary purpose of meeting the country?s basic economic and social needs. Immediate key measures taken after the revolution included free education up to  higher levels and free health services. In only a couple of decades Third World diseases were defeated and a First World health profile was achieved. In the sciences, support and collaboration was sought and welcomed from both Soviet and western countries. Moreover, due to the backward position of the Soviet Union in genetics and molecular biology, in the early 1970s Cuban scientists were trained in these fields mainly by Italian biologists. In the following decade, initially relying on contacts with American and Finnish specialists, Cuban biologists and physicians built a large industrial biotechnology complex to produce and commercialize Cuban-made, and often invented, medicines and vaccines. In the early 1990s the sudden collapse of the Soviet Union and the socialist market created an unprecedented challenge. Yet Cuba?s scientific system substantially resiled, despite unavoidable setbacks. This crisis was faced by confirming and reinforcing government support for biotechnology, with the result that today Cuba excels at a global level in the typical capital-intensive field of biotechnology. While this book is especially devoted to historians of science and technology and to biotechnologists, it is of interest to the general public.  . 410 0$aSpringerBriefs in History of Science and Technology,$x2211-4564 606 $aPharmaceutical technology 606 $aBiomedical engineering 606 $aBiotechnology 606 $aMedicine 606 $aPhysics 606 $aEthnology?Latin America 606 $aPharmaceutical Sciences/Technology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21010 606 $aBiomedical Engineering/Biotechnology$3https://scigraph.springernature.com/ontologies/product-market-codes/B24000 606 $aBiotechnology$3https://scigraph.springernature.com/ontologies/product-market-codes/C12002 606 $aMedicine/Public Health, general$3https://scigraph.springernature.com/ontologies/product-market-codes/H00007 606 $aPhysics, general$3https://scigraph.springernature.com/ontologies/product-market-codes/P00002 606 $aLatin American Culture$3https://scigraph.springernature.com/ontologies/product-market-codes/411080 615 0$aPharmaceutical technology. 615 0$aBiomedical engineering. 615 0$aBiotechnology. 615 0$aMedicine. 615 0$aPhysics. 615 0$aEthnology?Latin America. 615 14$aPharmaceutical Sciences/Technology. 615 24$aBiomedical Engineering/Biotechnology. 615 24$aBiotechnology. 615 24$aMedicine/Public Health, general. 615 24$aPhysics, general. 615 24$aLatin American Culture. 676 $a338.9729106 700 $aBaracca$b Angelo$4aut$4http://id.loc.gov/vocabulary/relators/aut$044102 702 $aFranconi$b Rosella$4aut$4http://id.loc.gov/vocabulary/relators/aut 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910253894303321 996 $aSubalternity vs. Hegemony, Cuba's Outstanding Achievements in Science and Biotechnology, 1959-2014$92532377 997 $aUNINA